Cargando…
Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990964/ http://dx.doi.org/10.1186/2051-1426-1-S1-P25 |
| _version_ | 1782312354905587712 |
|---|---|
| author | Nguyen, Linh T Butler, Marcus O Yen, Pei Hua Nie, Jessica Pniak, Michael Elford, Alisha R Joshua, Anthony M Hogg, David Ghazarian, Danny Al-Habeeb, Ayman Easson, Alexandra M Leong, Wey L McCready, David R Reedijk, Michael Messner, Hans A Ohashi, Pamela S |
| author_facet | Nguyen, Linh T Butler, Marcus O Yen, Pei Hua Nie, Jessica Pniak, Michael Elford, Alisha R Joshua, Anthony M Hogg, David Ghazarian, Danny Al-Habeeb, Ayman Easson, Alexandra M Leong, Wey L McCready, David R Reedijk, Michael Messner, Hans A Ohashi, Pamela S |
| author_sort | Nguyen, Linh T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3990964 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39909642014-05-01 Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy Nguyen, Linh T Butler, Marcus O Yen, Pei Hua Nie, Jessica Pniak, Michael Elford, Alisha R Joshua, Anthony M Hogg, David Ghazarian, Danny Al-Habeeb, Ayman Easson, Alexandra M Leong, Wey L McCready, David R Reedijk, Michael Messner, Hans A Ohashi, Pamela S J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990964/ http://dx.doi.org/10.1186/2051-1426-1-S1-P25 Text en Copyright © 2013 Nguyen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Nguyen, Linh T Butler, Marcus O Yen, Pei Hua Nie, Jessica Pniak, Michael Elford, Alisha R Joshua, Anthony M Hogg, David Ghazarian, Danny Al-Habeeb, Ayman Easson, Alexandra M Leong, Wey L McCready, David R Reedijk, Michael Messner, Hans A Ohashi, Pamela S Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title | Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title_full | Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title_fullStr | Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title_full_unstemmed | Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title_short | Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| title_sort | development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990964/ http://dx.doi.org/10.1186/2051-1426-1-S1-P25 |
| work_keys_str_mv | AT nguyenlinht developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT butlermarcuso developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT yenpeihua developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT niejessica developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT pniakmichael developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT elfordalishar developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT joshuaanthonym developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT hoggdavid developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT ghazariandanny developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT alhabeebayman developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT eassonalexandram developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT leongweyl developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT mccreadydavidr developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT reedijkmichael developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT messnerhansa developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy AT ohashipamelas developmentofanadoptivecelltherapyprotocolwithtumorinfiltratinglymphocytesandintermediatedoseinterleukin2therapy |